What Percentage of Zantac Users Were Diagnosed With Cancer?
A research team at Memorial Sloan Kettering Cancer Center and Valisure compared ranitidine, the active ingredient in Zantac, and other histamine-2 blockers in more than 10,000 cancer patients. The researchers identified a link between ranitidine use and cancers of the breast, thyroid, bladder, and prostate. Their study was published as a pre-print and has not yet been peer-reviewed.
In another study, scientists looked at a cohort of nearly 460,000 people from the U.K. Biobank and found more than 26,000 diagnosed with cancer. Of these, 1.9% reported taking ranitidine; however, the researchers found no association between the drug and overall cancer risk. They did find that the patients who took ranitidine regularly for an extended period of time were 1.9 times more likely to be diagnosed with liver cancer.
What Are the Symptoms of Zantac Cancer?
Common Zantac cancer symptoms may include:
- A change in size or shape of your stool
- A loss of appetite
- A lump in your side or abdomen
- A pain in your side that doesn't go away
- Abdominal pain or a cramping pain in your lower stomach
- Abdominal swelling
- Bloating or full feeling
- Blood in the stool or toilet after a bowel movement
- Blood in your urine
- Change in appetite
- Coughing or chest pain
- And more
What Is Zantac Called Now?
In early 2022, Zantac relaunched with a new name and a different active ingredient — Zantac 360 (generic: famotidine). Famotidine and ranitidine are both H2 blockers and work similarly to treat heartburn, acid reflux, and gastroesophageal reflux disease (GERD).
What Did They Replace Ranitidine With?
The FDA lists 2 alternatives for H2 histamine receptor antagonists as safe replacements for ranitidine: Pepcid (famotidine) and Tagamet (cimetidine).
Should I Be Worried if I Took Zantac?
The FDA is advising patients who take ranitidine-containing drugs to stop and consult their physician about alternatives for treating heartburn and other issues. The risk of cancer increases with cumulative exposure to NDMA products, FDA said.
See all related dangerous drug lawsuits we've taken on.
Get a Free Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in lawsuits. We are handling individual litigation nationwide and currently accepting new Zantac-induced cancer cases in all 50 states.
Again, If you or a loved one was diagnosed with cancer after taking Zantac, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.